compound · derived
Upadacitinib
2 trials · 1 approval
| Trials | 2 |
|---|---|
| Approvals | 1 |
| Phases | Phase 3 |
Provenance
- Source: Derived from ClinicalTrials.gov and openFDA
- Fetched at: 2026-10-28T02:31:39.072Z
- Licence class: internal-only
- Verdict: derived
- Entity id: upadacitinib
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.